Archives
-
Antiseptics for Burns: Evidence and Research Gaps
2026-08-25
The Cochrane review found that comparative evidence for antiseptics in burn care is limited, heterogeneous, and generally too uncertain to establish clear superiority for wound healing, infection prevention, or safety. Its main contribution is a structured appraisal of clinically relevant comparisons and a clear framework for designing better trials with standardized outcomes and follow-up.
-
Cytosolic DNA and TDP-43 Homeostasis
2026-08-24
A 2024 Journal of Biological Chemistry study identifies cytosolic DNA accumulation as a trigger for reversible TDP-43 condensates, nuclear TDP-43 depletion, and increased production of a short TDP-43 isoform. Its combination of cellular, genetic, and in vitro phase-separation experiments connects DNA mislocalization with mechanisms relevant to ALS and other TDP-43 proteinopathies.
-
HRD1-SEL1L, p97, and Stress Granule Homeostasis
2026-08-24
The 2024 iScience study identifies the HRD1-SEL1L ubiquitin ligase as a stressor-dependent regulator of heat shock-induced stress granules. Its mechanistic data connect ER quality control and the BiP-PERK-eIF2α axis with ubiquitin-proteasome system and p97 activity, providing a framework for studying condensate homeostasis in proteotoxic stress.
-
SmD2 Acetylation Links Splicing to PARP Sensitivity
2026-08-23
A 2024 Nature Communications study identifies acetylation-dependent control of the spliceosome protein SmD2 as a link between alternative splicing, DNA-damage repair, and PARP-inhibitor response in hepatocellular carcinoma. The findings support SmD2, BRCA1/FANC cassette-exon regulation, and HDAC2-associated stability as mechanistic biomarkers for evaluating olaparib combinations in preclinical HCC models.
-
Ferrostatin-1 (Fer-1): Mechanism and Use
2026-08-22
Ferrostatin-1, also called Fer-1, is a selective research inhibitor used to test ferroptosis driven by lipid peroxidation. Its reported cellular EC50 is approximately 60 nM against erastin-induced ferroptosis, while formulation and storage constraints require careful solvent and handling controls.
-
Chronic Stress, Mitochondria, and MnTBAP in Rats
2026-08-22
This 2025 rat study connects chronic unpredictable mild stress with mitochondrial dysfunction and neuroinflammation in the hippocampus and prefrontal cortex. Its key mechanistic contribution is the use of intracerebroventricular MnTBAP rescue to test whether mitochondrial oxidative imbalance contributes to stress-induced depression-like behavior.
-
RNA Clean and Concentrator Kit for IVT RNA
2026-08-21
Translate mechanistic mitophagy findings into cleaner, more reproducible RNA assay workflows with a membrane-based cleanup strategy. The RNA Clean and Concentrator Kit is especially useful for removing NTPs, enzymes, salts, and short oligonucleotides from in vitro transcription products before RT-qPCR, labeling, or functional testing.
-
AG-490: JAK2/EGFR Assay Workflows
2026-08-20
This scenario-based guide explains how AG-490 (JAK2/EGFR inhibitor), SKU A4139, can support reproducible viability, proliferation, and signaling experiments. It connects target potency, solvent preparation, pathway controls, and vendor-selection criteria to cancer research and immunopathological models.
-
EZ Cap EGFP mRNA 5-moUTP: Assay Workflow
2026-08-20
Build more reproducible reporter, delivery, translation, viability, and imaging assays with a Cap1- and 5-moUTP-modified EGFP transcript. This practical guide connects product handling to redox-responsive coacervate research and shows how to separate delivery failure from translation or cell-health effects.
-
PTH (1-34) for Bone and Kidney Translation
2026-08-19
A mechanistic and strategic guide to using Parathyroid hormone (1-34) (human) as a controlled receptor agonist across bone metabolism research, osteoporosis models, and emerging kidney assembloid platforms.
-
Liproxstatin-1 HCl: Ferroptosis Assay Guide
2026-08-19
Liproxstatin-1 HCl provides a selective rescue control for lipid peroxidation-driven cell death, helping researchers distinguish ferroptosis from apoptosis and nonspecific oxidative injury. This guide translates mitochondrial calcium–GPX4 findings into practical cell-based workflows and cautious extensions to acute renal failure and hepatic ischemia/reperfusion injury models.
-
Camostat Mesilate: Reliable Cell Assay Design
2026-08-18
Learn how Camostat Mesilate (SKU B2082) can support interpretable viability, proliferation, and cytotoxicity workflows by separating protease-pathway effects from nonspecific cell injury. This scenario-based guide covers mechanism, solvent controls, dose-ranging, storage, data interpretation, and practical vendor selection.
-
Metabolic Sensitization of Ferroptosis and Cuproptosis
2026-08-18
The reference study presents SCu/L, a copper–tannic acid/liposome nanosystem carrying STF-31, to inhibit glycolysis and compensatory NAD+ metabolism while increasing tumor-cell susceptibility to ferroptosis and cuproptosis. Its broader significance is the integration of metabolic depletion, copper retention, immunogenic cell death, and tumor immune-microenvironment remodeling in one treatment strategy.
-
Metabolic Intervention for Ferroptosis and Cuproptosis
2026-08-17
The reference study presents SCu/L, a copper-based nanosystem that combines glycolysis and NAD+ metabolic inhibition with copper delivery to synchronously sensitize tumors to ferroptosis and cuproptosis. Its findings connect reduced energy and redox defenses with impaired copper efflux, immunogenic cell death, and stronger antitumor immunity, while also highlighting the need for careful mechanistic controls.
-
Brain-to-Spinal Control of Mechanical Allodynia
2026-08-17
The reference study identifies a contralateral lPBNOprm1–dmHPdyn–spinal dorsal horn pathway that regulates both the laterality and persistence of mechanical allodynia in mice. Its combination of projection-defined circuit perturbations and behavioral pain models provides a framework for separating mechanisms that open bilateral pain gates from those that sustain hypersensitivity.